ISTA PHARMACEUTICALS INC·4

Feb 1, 7:18 PM ET

Davis Glenn Eugene 4

4 · ISTA PHARMACEUTICALS INC · Filed Feb 1, 2012

Insider Transaction Report

Form 4
Period: 2012-01-30
Davis Glenn Eugene
VP Legal & Chief Comp. Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2012-01-30$8.10/sh314$2,54329,519 total
Footnotes (1)
  • [F1]25% of the original award vested. A portion of the vested shares were traded to cover income taxes.

Documents

1 file
  • 4
    rrd332239.xmlPrimary

    DAVIS GLENN EUGENE--FORM 4